Drug intelligence / Profile preview

Danshen granules

Development stage
Unknown
Lead developer
Zhongjian Kangqiao Pharmaceutical
Administration
Oral
01

Overview

Danshen granules are a traditional Chinese medicine (TCM) formulation derived from the dried root and rhizome of *Salvia miltiorrhiza* (Danshen). Developed and manufactured by Zhongjian Kangqiao Pharmaceutical, this oral granule formulation is primarily indicated for the treatment of cardiovascular diseases, particularly those characterized by blood stasis, such as chest pain (angina pectoris) and palpitations. The pharmacological profile of Danshen is attributed to its bioactive components, including lipid-soluble tanshinones and water-soluble salvianolic acids. These constituents are known to improve microcirculation, inhibit platelet aggregation, exert anti-inflammatory effects, and provide myocardial protection against ischemia-reperfusion injury. The product is an approved medicine in China, categorized under cardiovascular TCM products.

Brand names
Danshen Keli
Other names
Salvia miltiorrhiza granules丹参颗粒
02

Targets

PI3K (Phosphoinositide-3-kinase regulatory subunit 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PDIA3 (Membrane-associated rapid response steroid-binding receptor)

Beyond the preview

Go deeper on Danshen granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Danshen granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call